These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1756876)

  • 1. The clinical use of an antibiotic-bonded graft.
    Strachan CJ; Newsom SW; Ashton TR
    Eur J Vasc Surg; 1991 Dec; 5(6):627-32. PubMed ID: 1756876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic efficacy against Staphylococcus epidermidis adherent to vascular grafts.
    Bergamini TM; McCurry TM; Bernard JD; Hoeg KL; Corpus RA; James BE; Peyton JC; Brittian KR; Cheadle WG
    J Surg Res; 1996 Jan; 60(1):3-6. PubMed ID: 8592428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis against Staphylococcus epidermidis vascular graft infection with rifampicin-soaked, gelatin-sealed Dacron.
    Sardelic F; Ao PY; Taylor DA; Fletcher JP
    Cardiovasc Surg; 1996 Jun; 4(3):389-92. PubMed ID: 8782944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of vascular graft infection by in situ replacement with a rifampin-bonded gelatin-sealed Dacron graft.
    Goëau-Brissonnière O; Mercier F; Nicolas MH; Bacourt F; Coggia M; Lebrault C; Pechère JC
    J Vasc Surg; 1994 Apr; 19(4):739-41. PubMed ID: 8164289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection?
    Vicaretti M; Hawthorne W; Ao PY; Fletcher JP
    Int Angiol; 1999 Sep; 18(3):225-32. PubMed ID: 10688422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limitations in the use of rifampicin-gelatin grafts against virulent organisms.
    Koshiko S; Sasajima T; Muraki S; Azuma N; Yamazaki K; Chiba K; Tachibana M; Inaba M
    J Vasc Surg; 2002 Apr; 35(4):779-85. PubMed ID: 11932679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection?
    Vicaretti M; Hawthorne W; Ao PY; Fletcher JP
    Int Angiol; 2000 Jun; 19(2):158-65. PubMed ID: 10905800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo effects of rifampin on Staphylococcus epidermidis graft infections.
    Garrison JR; Henke PK; Smith KR; Brittian KR; Lam TM; Peyton JC; Bergamini TM
    ASAIO J; 1997; 43(1):8-12. PubMed ID: 9116358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycationic peptides as prophylactic agents against methicillin-susceptible or methicillin-resistant Staphylococcus epidermidis vascular graft infection.
    Giacometti A; Cirioni O; Ghiselli R; Goffi L; Mocchegiani F; Riva A; Scalise G; Saba V
    Antimicrob Agents Chemother; 2000 Dec; 44(12):3306-9. PubMed ID: 11083632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prophylactic efficacy of rifampicin-soaked graft in combination with systemic vancomycin in the prevention of prosthetic vascular graft infection: an experimental study.
    Sacar M; Goksin I; Baltalarli A; Turgut H; Sacar S; Onem G; Ozcan V; Adali F
    J Surg Res; 2005 Dec; 129(2):329-34. PubMed ID: 16360378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An increased concentration of rifampicin bonded to gelatin-sealed Dacron reduces the incidence of subsequent graft infections following a staphylococcal challenge.
    Vicaretti M; Hawthorne WJ; Ao PY; Fletcher JP
    Cardiovasc Surg; 1998 Jun; 6(3):268-73. PubMed ID: 9705099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of rifampin-soaked gelatin-sealed polyester grafts for in situ treatment of primary aortic and vascular prosthetic infections.
    Bandyk DF; Novotney ML; Johnson BL; Back MR; Roth SR
    J Surg Res; 2001 Jan; 95(1):44-9. PubMed ID: 11120634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and duration of antistaphylococcal activity comparing three antibiotics bonded to Dacron vascular grafts with a collagen release system.
    Chervu A; Moore WS; Chvapil M; Henderson T
    J Vasc Surg; 1991 Jun; 13(6):897-901. PubMed ID: 1828092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic susceptibility of coagulase-negative staphylococcal blood isolates with special reference to adherent, slime-producing Staphylococcus epidermidis strains.
    Kotilainen P; Nikoskelainen J; Huovinen P
    Scand J Infect Dis; 1991; 23(3):325-32. PubMed ID: 1882198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of the resistance of arterial allografts to infection: comparative study with synthetic prostheses.
    Camiade C; Goldschmidt P; Koskas F; Ricco JB; Jarraya M; Gerota J; Kieffer E
    Ann Vasc Surg; 2001 Mar; 15(2):186-96. PubMed ID: 11265083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The acquisition of antibiotic resistant coagulase-negative staphylococci by aortic graft recipients.
    Mannion PT; Thom BT; Reynolds CS; Strachan CJ
    J Hosp Infect; 1989 Nov; 14(4):313-23. PubMed ID: 2575630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linezolid alone and in combination with rifampicin prevents experimental vascular graft infection due to methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Sacar M; Sacar S; Kaleli I; Onem G; Turgut H; Goksin I; Ozcan V; Kaan Inan B; Duver H; Baltalarli A
    J Surg Res; 2007 May; 139(2):170-5. PubMed ID: 17292421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antistaphylococcal activity of rifampin-bonded gelatin-impregnated Dacron grafts.
    Gahtan V; Esses GE; Bandyk DF; Nelson RT; Dupont E; Mills JL
    J Surg Res; 1995 Jan; 58(1):105-10. PubMed ID: 7830398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial activity, antibiotic retention, and infection resistance of a rifampin-impregnated gelatin-sealed Dacron graft.
    Lachapelle K; Graham AM; Symes JF
    J Vasc Surg; 1994 Apr; 19(4):675-82. PubMed ID: 8164283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro Evidence of Improved Antimicrobial Efficacy of Silver and Triclosan Containing Vascular Grafts Compared with Rifampicin Soaked Grafts.
    Berard X; Puges M; Pinaquy JB; Cazanave C; Stecken L; Bordenave L; Pereyre S; M'Zali F
    Eur J Vasc Endovasc Surg; 2019 Mar; 57(3):424-432. PubMed ID: 30301647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.